Clin2
NCT06225570Possibly a fitRecruiting

Weekly isotretinoin vs tetracycline for moderate acne

Acne Vulgaris

Treatments studied

Part of Skin clinical trials.

This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
50 people
Ages
12 years and older
Study type
Interventional

Who can take part

  • You are 12 years old or older.
  • You have moderate acne (not mild or severe).
  • You have not taken isotretinoin (Accutane) in the past 6 months.
  • You are not pregnant, planning to become pregnant, or breastfeeding.
  • You do not have active serious mental health issues (like major depression, mania, or psychosis) in the past year.
  • You do not have kidney or liver disease, high triglycerides, or a history of pseudotumor cerebri.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07639073Not yet recruiting· Phase 4
Low-dose vs standard-dose isotretinoin for moderate to severe acne

This study compares two different dosages of isotretinoin (a powerful acne medication) to see which works better and causes fewer side effects. Isotretinoin is typically used for acne that hasn't improved with other treatments.

Islamabad
NCT06447480Recruiting· Phase 3
Comparing isotretinoin to standard care for moderate acne in darker skin

This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.

Nice, Alpes-Maritimes
NCT07054398Recruiting
Catestatin levels in acne patients

This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.

Aswān
NCT06725290Not yet recruiting
Dry eye relief for acne patients on isotretinoin

This trial tests a treatment for dry eyes caused by isotretinoin, a drug used for severe acne. It aims to help people with moderate to severe acne who are already taking isotretinoin and experiencing dry eye symptoms.

NCT03883269Recruiting· Phase 4
Tests topical antibiotics’ anti-inflammatory effect in acne

This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.

Leiden
NCT07539129Not yet recruiting
Probiotics vs. Placebo for Moderate Acne

This study tests whether taking oral probiotics (live beneficial bacteria) can help reduce acne breakouts and inflammation in teenagers and young adults. Researchers want to see if probiotics work better than a placebo (inactive pill) for moderate acne.

Rawalpindi, Punjab Province

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.